Show results for
Refine by
Proteomics Services Available In Cuba
85 services found
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
With ongoing advancements in proteomics mass spectrometry technology, there has been a notable increase in the precision of analytical instruments, resulting in a richer dataset. While this detailed protein data is invaluable for deeper scientific investigation, the vast volumes of data produced by high-throughput proteomic screenings introduce substantial ...
by:Nautilus Biotechnology based inSeattle, WASHINGTON (USA)
As we begin to scratch the surface of the true complexity and nuance of human health and disease, a breakthrough increase in proteomics analysis throughput will allow researchers to measure at the scale needed to power the studies needed to quickly and cost effectively discover these new diagnostic ...
by:Nautilus Biotechnology based inSeattle, WASHINGTON (USA)
At Nautilus, our philosophy is to engage with the broader scientific community and utilize our technology and expertise to enable novel, high impact, proteomic discoveries. We are now providing access to our technology for a select group of collaborators. Currently, we are exploring research across a wide range of fields, including oncology, neuroscience, infectious disease, ...
Manufactured by:Creative Biogene-Mitochondrial Research based inNY, NEW YORK (USA)
Creative Biogene is committed to mitochondrial research, providing global customers with mitochondrial genomics services, mitochondrial proteomics services, and other custom mitochondrial research services. We have advanced platforms, equipment, a team of experts with rich experience, and standard system processes to offer state-of-the-art mitochondrial custom services to our ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Proteolysis targeting chimera (PROTAC) drugs offer a novel approach to disease treatment by leveraging the body's innate protein degradation pathways. In contrast to traditional small-molecule inhibitors, PROTAC drugs promote the degradation of specific proteins rather than directly inhibiting their function, thus mitigating or eliminating their role in disease progression. ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Antibodies bind to various antigens with high affinity and specificity, playing a crucial role in adaptive immune response to infections and can also mediate autoimmune diseases by targeting self-antigens. Antibodies facilitate immunity by inhibiting critical stages of a pathogen's replication cycle, such as receptor binding and cellular entry, activating the complement system, or initiating ...
Manufactured by:Proteomics International based inNedlands, Perth, AUSTRALIA
Comprehensive suite of new pre-clinical and clinical testing capabilities: pharmacokinetic (PK), pharmacodynamic (PD), and companion diagnostic (CDx) services. Proteomics International applies its proven expertise and experience in targeted mass spectrometry to the field of PK testing. Mass spectrometry is ideal for the accurate and precise quantitation of target drugs and their ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Protein-based macromolecular drugs, typically organic compounds with molecular weights exceeding 1000, depend on cellular biosynthesis and are also known as biologics. Compared to traditional small molecule drugs, protein drugs are characterized by their high potency, strong specificity, low toxicity, clear biological function, and conducive to clinical application. Protein drugs are the ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
PROTACs represent a novel strategy for protein degradation that has gained prominence recently. Utilizing bifunctional molecules, PROTACs enable the targeted ubiquitination and subsequent degradation of proteins via the UPS. PROTACs can not only offer potential therapeutic applications for a variety of conditions, including cancer, immune dysregulation, viral infections, and neurodegenerative ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Compared with genetic biomarkers, protein biomarkers provide higher degrees of differential information. Olink proteomics is based on a unique proximity extension assay (PEA) technique that enables simultaneous quantification of multiple protein ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
Drug affinity responsive target stability is a label-free small molecule probe technique under chemical proteomics first proposed by Lomenick et al. in 2009, which makes it possible to track and identify target proteins whose stability changes after binding with small molecules. To date, Drug affinity responsive target stability has been a focus in tracking proteins in animals, ...
by:MtoZ Biolabs based in, MASSACHUSETTS (USA)
With the rapid development of biotechnology, drug research and development has gradually entered a new era of precision and personalization. Targeted Protein Degradation (TPD) drugs are an emerging therapeutic strategy that utilizes the body's ubiquitin-proteasome system to degrade specific pathological proteins to achieve precise treatment. As an important new class of therapeutic drugs, TPD ...
Manufactured by:Ultima Genomics based inFremont, CALIFORNIA (USA)
Our Technology Access Program offers accessible entry to the UG 100™ through our in-house applications lab. Sequence on our high-capacity fleet of UG 100 Sequencers and receive support at every step, from consultation through data analysis. Connect ...
by:Advaita Bioinformatics based inAnn Arbor, MICHIGAN (USA)
AdvaitaBio’s founder, Dr. Sorin Draghici, was the Director of the Bioinformatics Core in one of NIH’s designated Comprehensive Cancer Centers. In that position, he got frustrated with the typical interactions between the Core and its customers. The typical back and forth between the Core and its customers can lead to wasted time and frustration for everybody ...
by:Indivumed GmbH based inHamburg, GERMANY
IndivuType uses our highest quality biospecimens and clinical data, combined with leading-edge analytical methods, to offer a unique multi-omics database. Thus, providing new insights into the biology of cancer and enabling new discoveries in the postgenomic ...
by:Excelra based inIselin, NEW JERSEY (USA)
Drug discovery is a complex process with many steps. It begins by finding the right targets and identifying groups of patients who will respond well to treatments. Each step has its own challenges and requires specific skills and solutions. At Excelra, our Computational Biology (CB) team blends technical skills with a solid understanding of biology. This allows us to offer clear and helpful ...
by:Indivumed GmbH based inHamburg, GERMANY
Once a target is identified the various effects of the drug can be measured. This involves all read-outs we use during the biomarker validation but instead of looking at the effect of various candidates we focus on one component. As the tumor microenvironment can play an important role we focus especially on test methods involving fresh tissue. ...
by:Indivumed GmbH based inHamburg, GERMANY
Cancer immunology, or “immuno-oncology,” is a growing field of research that aims to discover innovative cancer immunotherapies to treat and impede the progression of the disease. Understanding how cancer evades the immune system is the basis of immuno-oncology. With Indivumed’s scientific support you can, for example, identify the different types of immune cells and their ...
Manufactured by:CENTOGENE N.V. based inRostock, GERMANY
We work with partners to develop new disease models and new biomarkers of disease. We can also use our disease models to identify new drug targets and screen chemical compounds to identify potential new drug candidates. CENTOGENE provides companies with tools to accelerate drug discovery. From population screening studies that elucidate the prevalence of a rare disease to disease modeling, we are ...
by:Cmbio based inCopenhagen, DENMARK
Unlock deeper insights into microbial communities with our specialized Long-Read Metagenomics services. Utilizing long-read sequencing with Oxford Nanopore Technologies (ONT), we provide highly contiguous assemblies and high-quality metagenome-assembled genomes (MAGs) from complex samples such as soil, wastewater, and gastrointestinal ...